Article Text

PDF

Correspondence
Epithelial mesenchymal transition (EMT) in small airways of COPD patients
  1. Sukhwinder Singh Sohal,
  2. Eugene Haydn Walters
  1. NHMRC Centre of Research Excellence for Chronic Respiratory Disease, School of Medicine, University of Tasmania, Hobart, Australia
  1. Correspondence to Professor Eugene Haydn Walters, NHMRC Centre for Research Excellence in Chronic Respiratory Disease and School of Medicine, MS1, 17 Liverpool Street, Private Bag 23, Hobart, Tasmania 7000, Australia; haydn.walters{at}utas.edu.au, sssohal{at}utas.edu.au

Statistics from Altmetric.com

We congratulate Milara et al 1 for getting a paper suggesting that epithelial mesenchymal transition (EMT) is important in the pathogenesis of chronic obstructive pulmonary disease (COPD) into a top respiratory journal. This is quite a breakthrough.

In the discussion, Milara et al were somewhat dismissive of our findings on EMT markers in large airways of COPD patients;2 commenting that our study was limited by the mesenchymal protein expressions analysed (MMP-9, S100A4, vimentin) being potentially expressed by inflammatory cells. In a follow-up paper3 we excluded such confounding. Further, our study illustrated that cells in the basal epithelium, and reticular basement membrane (Rbm) in smokers/COPD double-stain for cytokeratin-(s) and the ‘EMT marker’ S100A4, confirming a likely epithelial origin of these cells. Notably, Milara et al also stained their tissue with vimentin.

The authors also queried the relevance of our findings on larger airways EMT to COPD. A major feature of COPD, in addition to small airway destruction, is its association with lung (airway) cancer. We have found large airway EMT to be associated with increased angiogenesis; this is a process reminiscent of EMT-type 3, a procancer stroma in contrast with the more specifically profibrotic EMT-type-2 which lacks angiogenesis.4–6 Active EMT-type-3 in large airways might be the link between COPD and lung cancer development.

For adherens proteins E-cadherin and ZO-1, the authors reported no staining in the smokers/COPD patients’ epithelium, suggesting their expression is lost as the part of EMT. It is true that E-cadherin and ZO-1 epithelial expression does decrease during EMT, but if disappeared completely the epithelium would fall apart. Their protein analysis and immunofluorescence data on primary human bronchial epithelial cells does show E-cadherin and ZO-1 expression, albeit decreased. We have also been looking at small airways in smokers and see a lot of E-cadherin staining but also N-cadherin expression, as another likely expression of EMT (figure 1).

Figure 1

Small airways in surgically resected lung sections from smokers undergoing thoracotomy: (A) black arrows indicating E-cadherin expression in the epithelium; (B) black arrows indicating N-cadherin expression in the epithelium.

Rbm fragmentation2 which is a vital part of the EMT process4 is evident in the small airway tissue sections shown in the Milara et al paper, as is hypercellularity of the Rbm. However, neither important structural hallmark of EMT is commented upon. The arrows pointing out α-SMA staining, which is below the Rbm, seem to be in the wrong place.

In spite of our reservations, this study highlights the potential importance of EMT in COPD, which might change the way we think about this disease process and its nasty clinical consequences.

References

View Abstract

Footnotes

  • Contributors SSS: literature search, figures, performed the histological analyses, data collection, data interpretation and writing. EHW: design of study, clinical assessments, overview of all analyses, data interpretation and writing.

  • Competing interests None.

  • Ethics approval The Human Research Ethics Committee (Tasmania) Network.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles